Dampening of mast cell secondary responses to allergen involves specific signalling and epigenetic changes.

Dampening of mast cell secondary responses to allergen involves specific signalling and epigenetic changes. Cell Immunol. 2019 Jun 08;:103944 Authors: Varma R, Puri N Abstract Allergic diseases are increasing worldwide. Allergen and IgE dependent mast cell (MC) activation is the major initiator of these clinical symptoms. During this study, the effect of multiple exposures to the same allergen, on MC degranulation was studied. First, MC recovery in terms of surface expression of high affinity receptor FcεRI, and granule content after a primary allergen challenge was confirmed. Overall, previous exposure of MCs to allergen challenge led to a significant reduction in pre-stored mediator release during the secondary challenge at various time points and with various doses of allergen in vitro. The dampened response was not due to any defects in very early steps in signalling involving FcεRI activation. Inhibition of dampening response during secondary challenge by various inhibitors like wortmannin, tranylcypromine and pargyline, indicated the involvement of PI3K signalling and chromatin modifications. Our study provides insight into new therapeutic avenues for treating allergic disorders targeting MCs. PMID: 31213284 [PubMed - as supplied by publisher]
Source: Cellular Immunology - Category: Allergy & Immunology Authors: Tags: Cell Immunol Source Type: research